Walking Pneumonia
Walking Pneumonia - Related Videos
09:17
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
0 Views •
Cited by 17 •
2017
A method for establishing lung infections in immunocompetent rodents is described. With proficiency, this method can be performed quickly and easily to induce stable infection with many isolates of S. pneumoniae, H. influenzae, P. aeruginosa, K. pneumoniae and A. baumannii.
09:38
The Ladder Rung Walking Task: A Scoring System and its Practical Application.
0 Views •
Cited by 305 •
2009
The ladder rung walking task is a new test to assess skilled walking and measure both forelimb and hindlimb placing, stepping, and inter-limb co-ordination.
13:27
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
0 Views •
Cited by 50 •
2014
Pneumonia is one of the top ten leading causes of death in the U.S. Osteopathic manipulative techniques (OMT) may be utilized as an adjunctive therapy in the treatment of pneumonia to enhance biomechanical and immune function; and ultimately, to reduce hospital stay, duration of antibiotics, incidence of respiratory failure, and mortality. In this video-article, we will review randomized controlled studies on the use of OMT in pneumonia patients, as well as demonstrate specific hands-on...
07:21
Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
0 Views •
Cited by 5 •
2023
The present protocol aims to inform rehabilitation specialists and fitness instructors in safe, feasible, and evidence-based methods of delivering virtual and in-person walking classes to older adults with neurodegenerative diseases.
07:24
Production of Chemicals by Klebsiella pneumoniae Using Bamboo Hydrolysate as Feedstock
0 Views •
Cited by 1 •
2017
Bamboo powder was pretreated with NaOH and enzymatically hydrolyzed. The hydrolysate of bamboo was used as the feedstock for 2,3-butanediol, R-acetoin, 2-ketogluconic acid, and xylonic acid production by Klebsiella pneumoniae.
FAQs
Mycoplasma pneumoniae can infect airway and lung cells, prompting the host to mount an immune response. This interaction contributes to inflammation and increased mucus production in affected tissues. Studying the pathogen together with the host response helps biologists explain how cellular infection can progress to respiratory symptoms and altered lung function.
Inflammation affects the air sacs and surrounding lung tissues, while mucus can interfere with normal airflow. These changes may reduce the efficiency of gas exchange, but their extent can vary among infections. That variation helps explain why some people remain active even while biological changes are occurring in the lungs.
Symptoms alone may not clearly separate walking pneumonia from other respiratory infections because several conditions can produce similar respiratory complaints. Clinical investigation therefore considers the pattern of illness alongside information about likely pathogens and disease progression. Accurate distinction matters because diagnosis and treatment decisions depend on identifying the condition responsible for the lung inflammation.
The host immune response is part of the disease process, not merely a reaction observed afterward. As immune activity develops against an invading respiratory pathogen, it can contribute to inflammation in airway and lung tissues. Examining this response helps researchers connect pathogen infection with symptom development and assess why disease progression may differ between individuals.
Clinical investigation aims to identify the cause of respiratory symptoms, evaluate whether lung tissues are affected, and distinguish the illness from other infections with similar presentations. Investigators use this information to support accurate diagnosis and guide treatment. The process also connects biological findings, including inflammation and impaired gas exchange, with the patient’s clinical course.
Transmission studies examine how respiratory pathogens spread, while surveillance tracks the occurrence of illness across populations. Together, they help investigators recognize outbreaks and monitor patterns of disease. For walking pneumonia, this population-level information complements clinical diagnosis by showing where infections are increasing and supporting efforts to distinguish this condition from other respiratory infections.